Cancer Focus

$9,253P30FY2018CANIH

Medical University Of South Carolina, Charleston SC

Investigators

Linked publications, trials & patents

Paper 39716322 Paper 39561045 Paper 39554796 Paper 39391533 Paper 39379700 Paper 39347566 Paper 39312723 Paper 39292167 Paper 39264252 Paper 39225558 Paper 39146811 Paper 39108242 Paper 39046874 Paper 39037017 Paper 39000384 Paper 38980715 Paper 38945552 Paper 38885332 Paper 38856163 Paper 38853930 Paper 38853284 Paper 38824916 Paper 38802657 Paper 38779482 Paper 38752949 Paper 38709899 Paper 38681116 Paper 38668812 Paper 38632569 Paper 38617240 Paper 38570770 Paper 38570462 Paper 38546787 Paper 38546445 Paper 38515274 Paper 38509768 Paper 38464312 Paper 38417823 Paper 38381042 Paper 38373106 Paper 38365772 Paper 38364938 Paper 38352443 Paper 38329320 Paper 38329128 Paper 38319231 Paper 38273829 Paper 38255295 Paper 38222066 Paper 38200579 Paper 38194131 Paper 38177192 Paper 38174740 Paper 38164625 Paper 38136410 Paper 38081134 Paper 37977486 Paper 37967292 Paper 37961721 Paper 37942694 Paper 37914699 Paper 37902448 Paper 37828860 Paper 37822942 Paper 37819702 Paper 37806365 Paper 37803429 Paper 37745348 Paper 37745346 Paper 37731255 Paper 37720013 Paper 37609318 Paper 37566040 Paper 37560455 Paper 37481703 Paper 37461579 Paper 37427141 Paper 37399416 Paper 37382737 Paper 37338201 Paper 37333126 Paper 37322469 Paper 37268417 Paper 37211959 Paper 37126482 Paper 37092117 Paper 37081789 Paper 37071464 Paper 36993287 Paper 36913266 Paper 36909595 Paper 36868225 Paper 36864125 Paper 36828843 Paper 36803404 Paper 36749843 Paper 36743586 Paper 36710461 Trial NCT06451003 Trial NCT04237272

Abstract

Cancer Focus The Hollings Cancer Center (HCC) is fully committed to cancer research and has effectively utilized the CCSG award and designation as an NCI-Cancer Center in 2009 to further strengthen this focus. This commitment to cancer research is integral to all HCC activities. This continued focus is demonstrated by: 1) The increase in the substantial portfolio of basic, clinical, translational, and population-based research presented throughout this application; 2) The consistent growth in the numbers of cancer grants, publications, clinical research studies, and accrual to trials; 3) The expansion of the breadth and depth of the cancer focused research within each of the research programs and the maturation of a new Cancer Control Program; and 4) The increase in cancer-focused education and training opportunities. Features of the HCC that play a critical role in achieving and maintaining the cancer focus include the personal commitment of the Director and the senior leadership and their representation of many major departments of the Medical University of South Carolina (MUSC). This organizational infrastructure has enabled the HCC to fully engage the leadership of MUSC thereby ensuring a robust institutional commitment that further promotes the ability of the HCC to promote its agenda. These commitments have included the substantial increases in new research space devoted to the HCC described previously in Section 7.1 Facilities; enhancement of the depth and breadth of shared resources that enable cutting-edge research; and successful recruitment of innovative, cancer-focused investigators who are leaders in their respective fields. In parallel, the HCC has harnessed all available resources at MUSC, at the state level and nationally, to significantly augment its commitment to addressing cancers of particular concern within its specific catchment area, the State of South Carolina (SC), with a particular emphasis on tobacco control and addressing cancer disparities. The enrichment activities (retreats, seminar series, etc.) of the HCC are further used to consolidate and promote the cancer focus by bringing together basic researchers with clinical cancer investigators. The following provides demonstrable evidence of the cancer focus at the HCC.

View original record on NIH RePORTER →